A Study Evaluating the Safety of Stratagraft® Skin Tissue in Promoting Skin Tissue Regeneration of Complex Skin Defects Due to Thermal Burns
Status: openPhase 3 open-label, controlled, randomized, multicenter study evaluating the efficacy and safety of Stratagraft® skin tissue in promoting autologous skin tissue regeneration of complex skin defects due to thermal burns that contain intact dermal elements
Treatment for Thermal Burns
Description
The proposed registration study is designed as a phase III open-label, controlled, randomized, multicenter study evaluating the efficacy and safety of StrataGraft skin tissue in promoting autologous skin tissue regeneration of complex skin defects due to thermal burns.
Sponsors
This trial is sponsored by Stratatech.Interested in Clinical Trial?
Contact the Clinical Trial Coordinator
If you have questions get in touch with this Clinical Trial’s Coordinator by phone at 251-471-7988 or by email at kbose@health.southalabama.edu.
Providers Associated With This Trial
Principle Investigator
![Steven Kahn]()
View ProfileSteven Kahn, M.D.Burn/Trauma/Critical Care SurgeonDirector of Arnold Luterman Regional Burn Center; Director of Burn Intensive Care Unit; Assistant Professor of Surgery
Sub Investigators
![Lintner Alicia]()
View ProfileAlicia C. Lintner, CRNPNurse Practitioner
